BCRX logo

BioCryst Pharmaceuticals (BCRX) Working capital

annual working capital:

$261.58M-$84.39M(-24.39%)
December 31, 2024

Summary

  • As of today (May 29, 2025), BCRX annual working capital is $261.58 million, with the most recent change of -$84.39 million (-24.39%) on December 31, 2024.
  • During the last 3 years, BCRX annual working capital has fallen by -$200.83 million (-43.43%).
  • BCRX annual working capital is now -43.43% below its all-time high of $462.42 million, reached on December 31, 2021.

Performance

BCRX Working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXbalance sheet metrics

quarterly working capital:

$270.12M+$8.54M(+3.26%)
March 31, 2025

Summary

  • As of today (May 29, 2025), BCRX quarterly working capital is $270.12 million, with the most recent change of +$8.54 million (+3.26%) on March 31, 2025.
  • Over the past year, BCRX quarterly working capital has dropped by -$57.06 million (-17.44%).
  • BCRX quarterly working capital is now -41.58% below its all-time high of $462.42 million, reached on December 31, 2021.

Performance

BCRX quarterly working capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXbalance sheet metrics

Working capital Formula

Working Capital = Current Assets − Current Liabilities

BCRX Working capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-24.4%-17.4%
3 y3 years-43.4%-37.3%
5 y5 years+263.3%+723.3%

BCRX Working capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-43.4%at low-37.3%+15.2%
5 y5-year-43.4%+263.3%-41.6%+723.3%
alltimeall time-43.4%>+9999.0%-41.6%+2236.2%

BCRX Working capital History

DateAnnualQuarterly
Mar 2025
-
$270.12M(+3.3%)
Dec 2024
$261.58M(-24.4%)
$261.58M(-4.4%)
Sep 2024
-
$273.56M(+16.7%)
Jun 2024
-
$234.39M(-28.4%)
Mar 2024
-
$327.18M(-5.4%)
Dec 2023
$345.98M(-15.8%)
$345.98M(-16.0%)
Sep 2023
-
$411.70M(-1.4%)
Jun 2023
-
$417.56M(+2.9%)
Mar 2023
-
$405.73M(-1.3%)
Dec 2022
$410.99M(-11.1%)
$410.99M(-3.8%)
Sep 2022
-
$427.36M(+7.0%)
Jun 2022
-
$399.46M(-7.3%)
Mar 2022
-
$430.70M(-6.9%)
Dec 2021
$462.42M(+112.0%)
$462.42M(+288.1%)
Sep 2021
-
$119.14M(-20.7%)
Jun 2021
-
$150.20M(-13.0%)
Mar 2021
-
$172.57M(-20.9%)
Dec 2020
$218.15M(+202.9%)
$218.15M(+330.6%)
Sep 2020
-
$50.66M(-49.9%)
Jun 2020
-
$101.19M(+208.4%)
Mar 2020
-
$32.81M(-54.4%)
Dec 2019
$72.01M(+60.5%)
$72.01M(-2239.3%)
Sep 2019
-
-$3.37M(-110.6%)
Jun 2019
-
$31.77M(-38.1%)
Mar 2019
-
$51.32M(+14.4%)
Dec 2018
$44.88M(-11.2%)
$44.88M(-30.0%)
Sep 2018
-
$64.14M(+246.8%)
Jun 2018
-
$18.50M(-35.8%)
Mar 2018
-
$28.81M(-43.0%)
Dec 2017
$50.55M(+300.4%)
$50.55M(-52.4%)
Sep 2017
-
$106.13M(+218.5%)
Jun 2017
-
$33.33M(-39.3%)
Mar 2017
-
$54.95M(+335.1%)
Dec 2016
$12.63M(+721.5%)
$12.63M(-3.7%)
Sep 2016
-
$13.11M(-230.1%)
Jun 2016
-
-$10.08M(-20.3%)
Mar 2016
-
-$12.64M(-922.7%)
Dec 2015
$1.54M(-95.2%)
$1.54M(-92.3%)
Sep 2015
-
$20.06M(-53.7%)
Jun 2015
-
$43.32M(+122.1%)
Mar 2015
-
$19.50M(-39.1%)
Dec 2014
$32.05M(+19.3%)
$32.05M(-62.4%)
Sep 2014
-
$85.32M(-8.6%)
Jun 2014
-
$93.31M(+323.3%)
Mar 2014
-
$22.04M(-18.0%)
Dec 2013
$26.86M(+8.5%)
$26.86M(-20.2%)
Sep 2013
-
$33.66M(+56.0%)
Jun 2013
-
$21.57M(-10.4%)
Mar 2013
-
$24.08M(-2.7%)
Dec 2012
$24.75M(-6.8%)
$24.75M(-27.2%)
Sep 2012
-
$34.02M(+31.1%)
Jun 2012
-
$25.96M(-29.4%)
Mar 2012
-
$36.78M(+38.5%)
Dec 2011
$26.56M(-55.3%)
$26.56M(-35.4%)
Sep 2011
-
$41.11M(-29.0%)
Jun 2011
-
$57.92M(-26.4%)
Mar 2011
-
$78.68M(+32.4%)
Dec 2010
$59.42M(-19.5%)
$59.42M(-14.5%)
Sep 2010
-
$69.52M(+7.5%)
Jun 2010
-
$64.66M(-9.8%)
Mar 2010
-
$71.70M(-2.8%)
Dec 2009
$73.77M
$73.77M(+123.9%)
DateAnnualQuarterly
Sep 2009
-
$32.95M(-25.1%)
Jun 2009
-
$43.99M(-14.7%)
Mar 2009
-
$51.57M(-11.0%)
Dec 2008
$57.92M(-8.9%)
$57.92M(-7.4%)
Sep 2008
-
$62.55M(+63.4%)
Jun 2008
-
$38.27M(-25.4%)
Mar 2008
-
$51.31M(-19.3%)
Dec 2007
$63.59M(+81.4%)
$63.59M(-4.8%)
Sep 2007
-
$66.83M(+95.0%)
Jun 2007
-
$34.27M(+1.7%)
Mar 2007
-
$33.71M(-3.8%)
Dec 2006
$35.06M(-49.7%)
$35.06M(-2.0%)
Sep 2006
-
$35.75M(-30.7%)
Jun 2006
-
$51.56M(-15.2%)
Mar 2006
-
$60.79M(-12.8%)
Dec 2005
$69.72M(+231.4%)
$69.72M(+148.7%)
Sep 2005
-
$28.03M(-11.1%)
Jun 2005
-
$31.53M(-19.2%)
Mar 2005
-
$39.02M(+85.5%)
Dec 2004
$21.04M(+8.7%)
$21.04M(+3.9%)
Sep 2004
-
$20.26M(-10.6%)
Jun 2004
-
$22.65M(-15.7%)
Mar 2004
-
$26.86M(+38.8%)
Dec 2003
$19.36M(-19.5%)
$19.36M(+1.6%)
Sep 2003
-
$19.04M(-23.2%)
Jun 2003
-
$24.79M(+9.4%)
Mar 2003
-
$22.67M(-5.8%)
Dec 2002
$24.06M(-20.9%)
$24.06M(-10.7%)
Sep 2002
-
$26.95M(+2.2%)
Jun 2002
-
$26.37M(-7.3%)
Mar 2002
-
$28.44M(-6.5%)
Dec 2001
$30.42M(+40.6%)
$30.42M(-1.3%)
Sep 2001
-
$30.83M(+6.3%)
Jun 2001
-
$29.00M(-5.5%)
Mar 2001
-
$30.69M(+41.8%)
Dec 2000
$21.64M(-5.5%)
$21.64M(-15.2%)
Sep 2000
-
$25.52M(-0.4%)
Jun 2000
-
$25.63M(-1.8%)
Mar 2000
-
$26.09M(+13.9%)
Dec 1999
$22.90M(+5.0%)
$22.90M(+21.8%)
Sep 1999
-
$18.80M(+9.3%)
Jun 1999
-
$17.20M(-7.0%)
Mar 1999
-
$18.50M(-15.1%)
Dec 1998
$21.80M(+16.0%)
$21.80M(+1.9%)
Sep 1998
-
$21.40M(+15.7%)
Jun 1998
-
$18.50M(-3.1%)
Mar 1998
-
$19.10M(+1.6%)
Dec 1997
$18.80M(-29.6%)
$18.80M(-21.3%)
Sep 1997
-
$23.90M(-10.8%)
Jun 1997
-
$26.80M(+20.7%)
Mar 1997
-
$22.20M(-16.9%)
Dec 1996
$26.70M(+151.9%)
$26.70M(-19.1%)
Sep 1996
-
$33.00M(+94.1%)
Jun 1996
-
$17.00M(+1.8%)
Mar 1996
-
$16.70M(+57.5%)
Dec 1995
$10.60M(+2.9%)
$10.60M(-16.5%)
Sep 1995
-
$12.70M(-13.0%)
Jun 1995
-
$14.60M(+94.7%)
Mar 1995
-
$7.50M(-27.2%)
Dec 1994
$10.30M
$10.30M(-16.3%)
Sep 1994
-
$12.30M(+3.4%)
Jun 1994
-
$11.90M(+5.3%)
Mar 1994
-
$11.30M

FAQ

  • What is BioCryst Pharmaceuticals annual working capital?
  • What is the all time high annual working capital for BioCryst Pharmaceuticals?
  • What is BioCryst Pharmaceuticals annual working capital year-on-year change?
  • What is BioCryst Pharmaceuticals quarterly working capital?
  • What is the all time high quarterly working capital for BioCryst Pharmaceuticals?
  • What is BioCryst Pharmaceuticals quarterly working capital year-on-year change?

What is BioCryst Pharmaceuticals annual working capital?

The current annual working capital of BCRX is $261.58M

What is the all time high annual working capital for BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals all-time high annual working capital is $462.42M

What is BioCryst Pharmaceuticals annual working capital year-on-year change?

Over the past year, BCRX annual working capital has changed by -$84.39M (-24.39%)

What is BioCryst Pharmaceuticals quarterly working capital?

The current quarterly working capital of BCRX is $270.12M

What is the all time high quarterly working capital for BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals all-time high quarterly working capital is $462.42M

What is BioCryst Pharmaceuticals quarterly working capital year-on-year change?

Over the past year, BCRX quarterly working capital has changed by -$57.06M (-17.44%)
On this page